Literature DB >> 11055264

Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids.

C De Santi1, A Pietrabissa, R Spisni, F Mosca, G M Pacifici.   

Abstract

1. Resveratrol, a polyphenolic compound present in grape and wine, has beneficial effects against cancer and protective effects on the cardiovascular system. Resveratrol is sulphated, and the hepatic and duodenal sulphation might limit the bioavailability of this compound. The aim of this study was to see whether natural flavonoids present in wine, fruits and vegetables inhibit the sulphation of resveratrol in the human liver and duodenum. 2. In the liver, IC50 for the inhibition of resveratrol sulphation was 12+/-2 pM (quercetin), 1.0+/-0.04 microM (fisetin), 1.4+/-0.1 microM (myricetin), 2.2+/-0.1 microM (kaempferol) and 2.8+/-0.2 microM (apigenin). Similarly, in the duodenum, IC50 was 15+/-2 pM (quercetin), 1.3+/-0.1 microM (apigenin), 1.3+/-0.5 microM (fisetin), 2.3+/-0.1 microM (kaempferol) and 2.5+/-0.3 microM (myricetin). 3. The type of inhibition of quercetin on resveratrol sulphation was studied in three liver samples and was determined to be non-competitive and mixed in nature. Km (mean+/-SD; microM) was 0.23+/-0.07 (control), 0.40+/-0.08 (5 pM quercetin) and 0.56+/-0.09 (10 pM quercetin). Vmax (mean+/-SD; pmol min(-1) x mg(-1)) was 99+/-11 (control), 73+/-15 (5 pM quercetin) and 57 +/- 10 (10 pM quercetin). Kj and Kies estimates (mean+/-SD) were 3.7+/-1.8 pM and 12.1+/-1.7 pM respectively (p = 0.010). 4. Chrysin was a substrate for the sulphotransferase(s) and an assay was developed for measuring the chrysin sulphation rate in human liver. The enzyme followed Michaelis-Menten kinetics and Km and Vmax (mean+/-SD) measured in four livers were 0.29+/-0.07 microM and 43.1+/-1.9 pmol x min(-1) x mg(-1) respectively. 5. Catechin was neither an inhibitor of resveratrol sulphation nor a substrate of sulphotransferase. 6. These results are consistent with the view that many, but not all, flavonoids inhibit the hepatic and duodenal sulphation of resveratrol, and such inhibition might improve the bioavailability of this compound.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11055264     DOI: 10.1080/004982500433282

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  35 in total

1.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Authors:  Juma Hoshino; Eun-Jung Park; Tamara P Kondratyuk; Laura Marler; John M Pezzuto; Richard B van Breemen; Shunyan Mo; Yongchao Li; Mark Cushman
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

2.  Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.

Authors:  Sarah E St John; Katherine C Jensen; Soosung Kang; Yafang Chen; Barbara Calamini; Andrew D Mesecar; Mark A Lipton
Journal:  Bioorg Med Chem       Date:  2013-07-27       Impact factor: 3.641

Review 3.  Bioavailability of phytochemicals and its enhancement by drug delivery systems.

Authors:  Farrukh Aqil; Radha Munagala; Jeyaprakash Jeyabalan; Manicka V Vadhanam
Journal:  Cancer Lett       Date:  2013-02-19       Impact factor: 8.679

4.  Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.

Authors:  Charles la Porte; Nha Voduc; Guijun Zhang; Isabelle Seguin; Danielle Tardiff; Neera Singhal; D William Cameron
Journal:  Clin Pharmacokinet       Date:  2010-07       Impact factor: 6.447

Review 5.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

Review 6.  Resveratrol-based combinatorial strategies for cancer management.

Authors:  Chandra K Singh; Jasmine George; Nihal Ahmad
Journal:  Ann N Y Acad Sci       Date:  2013-07       Impact factor: 5.691

Review 7.  Resveratrol and cancer: Challenges for clinical translation.

Authors:  Chandra K Singh; Mary A Ndiaye; Nihal Ahmad
Journal:  Biochim Biophys Acta       Date:  2014-11-08

8.  Increased transport of resveratrol across monolayers of the human intestinal Caco-2 cells is mediated by inhibition and saturation of metabolites.

Authors:  Alexandra Maier-Salamon; Birgit Hagenauer; Michael Wirth; Franz Gabor; Thomas Szekeres; Walter Jäger
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 9.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

10.  Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.

Authors:  Radka Václavíková; Stanislav Horský; Petr Simek; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-08-14       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.